GPRIN1 and pancreatic adenocarcinoma: As shown in Figure 1(b), the expression of GPRIN1 in BLCA, BRCA, CHOL, ESCA, HNSC, KIRP, LUAD, LUSC, pancreatic adenocarcinoma (PAAD), STAD, and UCEC increased considerably, but it diminished significantly in GBM.